Jessica Jalbrzikowski

Outcome of Treatment for Congenital Toxoplasmosis, 1981-2004: The National Collaborative Chicago-Based, Congenital Toxoplasmosis Study

Rima McLeod, K. M. Boyer, Theodore Karrison et al. · Clinical Infectious Diseases · 2006 · 349 citations

BiRD (Biaxin [clarithromycin]/Revlimid [lenalidomide]/dexamethasone) combination therapy results in high complete- and overall-response rates in treatment-naive symptomatic multiple myeloma.

Rubén Niesvizky, David Jayabalan, Paul J. Christos et al. · Blood · 2007 · 182 citations · Full text

Longitudinal Study of New Eye Lesions in Children with Toxoplasmosis Who Were Not Treated During the First Year of Life

Laura Phan, Kristen Kasza, Jessica Jalbrzikowski et al. · American Journal of Ophthalmology · 2008 · 122 citations · Full text

New Eye Lesions, Ocular Disease, Ophthalmology +6

Lenalidomide‐induced myelosuppression is associated with renal dysfunction: adverse events evaluation of treatment‐naïve patients undergoing front‐line lenalidomide and dexamethasone therapy

Rubén Niesvizky, Tara Naib, Paul J. Christos et al. · British Journal of Haematology · 2007 · 89 citations · Full text

Longitudinal Study of New Eye Lesions in Treated Congenital Toxoplasmosis

Laura Phan, Kristen Kasza, Jessica Jalbrzikowski et al. · Ophthalmology · 2007 · 85 citations

Ocular Disease, Ophthalmology, Oculoplastics +3